In partnership with
Menu
In partnership with
| No. | Publication | Authors | More |
|---|---|---|---|
88 | Title: Reduced MC4R signaling alters nociceptive thresholds associated with red hair | Kathleen C. Robinson, Lajos V. Kemény, Gillian L. Fell, Andrea L. Hermann, Jennifer Allouche, Weihua Ding, Ajay Yekkirala, Jennifer J. Hsiao, Mack Y. Su, Nicholas Theodosakis, Gabor Kozak, Yuichi Takeuchi, Shiqian Shen, Antal Berenyi, Jianren Mao, Clifford J. Woolf, David E. Fisher | Year: 2021 Thematic Pillar: Genomic Instability and Cancer DOI: 10.1126/sciadv.abd1310 |
| 59 | Title: Closed-loop stimulation of the medial septum terminates epileptic seizures Journal/Proc./Book: Brain (1) | Yuichi Takeuchi, Márk Harangozó, Lizeth Pedraza, Tamás Földi, Gábor Kozák, Antal Berényi | Year: 2021 Thematic Pillar: Genomic Instability and Cancer DOI: 10.1093/brain/awaa450 Repository Link |
| 26 | Title: Robust high-throughput assays to assess discrete steps in ubiquitination and related cascades Journal/Proc./Book: BMC Molecular and Cell Biology (21/1) | Gabriel Fenteany, Paras Gaur, Gaurav Sharma, Lajos Pintér, Ernő Kiss, Lajos Haracska | Year: 2020 Thematic Pillar: Genomic Instability and Cancer DOI: 10.1186/s12860-020-00262-5 Repository Link |
| 18 | Title: Oscillotherapeutics – Time-targeted interventions in epilepsy and beyond Journal/Proc./Book: Neuroscience Research (152) | Yuichi Takeuchi, Antal Berényi | Year: 2019 Thematic Pillar: Genomic Instability and Cancer DOI: 10.1016/j.neures.2020.01.002 |
| 12 | Title: Multilevel structure–activity profiling reveals multiple green tea compound families that each modulate ubiquitin-activating enzyme and ubiquitination by a distinct mechanism Journal/Proc./Book: Scientific Reports (9/1) | Gabriel Fenteany, Paras Gaur, Lili Hegedűs, Kata Dudás, Ernő Kiss, Edit Wéber, László Hackler, Tamás Martinek, László G. Puskás, Lajos Haracska | Year: 2019 Thematic Pillar: Genomic Instability and Cancer DOI: 10.1038/s41598-019-48888-6 |
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.
© 2021 Hungarian Centre of Excellence for Molecular Medicine, all rights reserved. Hungarian Centre of Excellence for Molecular Medicine® and HCEMM® are registered trademarks of the the HCEMM Nonprofit Ltd.